3 ms·
> I would have thought they were pretty well positioned to find new targets for currently untreatable diseases To find new targets yes but to develop a drug to
by helsinkiandrew 3y ago
> I would have thought they were pretty well positioned to find new targets for currently untreatable diseases
To find new targets yes but to develop a drug to market (and revenue/profit) takes 10-15 years. Even a drug to a state that gets approved for human testing seems beyond what they could do themselves without so much funding it would wipe out the existing shareholders. Selling to/Partnering with other drug companies with targets they've discovered/IP from DNA etc would seem more realistic.
- toomuchtodo 3y agohttps://investors.23andme.com/news-releases/news-release-details/23andme-announces-collaboration-extension-new-data-licensing/ https://investors.23andme.com/news-releases/news-release-det...
- ackbar03 3y agoI would say target discovery is definitely no less important than drug discovery though. Biology is so complex, for a lot of diseases we aren't even sure the targets and pathways are valid. But then again, as per another commenter, I guess it's much harder than it seems, and probably not as easy to monetize as a drug